Doxa AB (publ) (DOXA.ST)
SEK 0.57
(4.63%)
SEK 0.57
(4.63%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.60 SEK | 1266.67% |
| 2022 | -0.12 SEK | -117.91% |
| 2021 | 0.67 SEK | 518.75% |
| 2020 | -0.16 SEK | -23.08% |
| 2019 | -0.13 SEK | -241.15% |
| 2018 | 0.09 SEK | 143.86% |
| 2017 | -0.21 SEK | -10.53% |
| 2016 | -0.19 SEK | 36.67% |
| 2015 | -0.30 SEK | -172.73% |
| 2014 | -0.11 SEK | 90.09% |
| 2013 | -1.11 SEK | 47.89% |
| 2012 | -2.13 SEK | 40.67% |
| 2011 | -3.59 SEK | -1695.0% |
| 2010 | -0.20 SEK | 62.96% |
| 2009 | -0.54 SEK | 47.57% |
| 2008 | -1.03 SEK | 5.5% |
| 2007 | -1.09 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 0.01 SEK | 101.75% |
| 2024 Q1 | -0.56 SEK | -19.15% |
| 2023 Q1 | -0.15 SEK | 61.54% |
| 2023 FY | - SEK | 1266.67% |
| 2023 Q2 | 0.64 SEK | 526.67% |
| 2023 Q4 | -0.47 SEK | -138.21% |
| 2023 Q3 | 1.23 SEK | 92.19% |
| 2022 Q1 | -0.03 SEK | -107.78% |
| 2022 FY | - SEK | -117.91% |
| 2022 Q4 | -0.39 SEK | -1297.85% |
| 2022 Q3 | -0.03 SEK | -109.0% |
| 2022 Q2 | 0.31 SEK | 1176.39% |
| 2021 FY | - SEK | 518.75% |
| 2021 Q2 | -0.07 SEK | -39.62% |
| 2021 Q3 | -0.05 SEK | 32.13% |
| 2021 Q4 | 0.37 SEK | 918.58% |
| 2021 Q1 | -0.05 SEK | -54.37% |
| 2020 Q1 | -0.03 SEK | -912.5% |
| 2020 Q3 | -0.05 SEK | 0.0% |
| 2020 Q2 | -0.05 SEK | -45.37% |
| 2020 Q4 | -0.03 SEK | 34.39% |
| 2020 FY | - SEK | -23.08% |
| 2019 Q4 | -0.00 SEK | 96.18% |
| 2019 FY | - SEK | -241.15% |
| 2019 Q3 | -0.08 SEK | -304.83% |
| 2019 Q2 | -0.02 SEK | 10.0% |
| 2019 Q1 | -0.02 SEK | 8.37% |
| 2018 FY | - SEK | 143.86% |
| 2018 Q4 | -0.03 SEK | -45.93% |
| 2018 Q3 | -0.02 SEK | -110.12% |
| 2018 Q1 | -0.04 SEK | -82.56% |
| 2018 Q2 | 0.17 SEK | 577.53% |
| 2017 FY | - SEK | -10.53% |
| 2017 Q3 | -0.05 SEK | 39.47% |
| 2017 Q2 | -0.08 SEK | -11.76% |
| 2017 Q1 | -0.07 SEK | -419.08% |
| 2017 Q4 | -0.02 SEK | 57.61% |
| 2016 Q3 | -0.05 SEK | 14.57% |
| 2016 Q2 | -0.06 SEK | 5.69% |
| 2016 Q4 | -0.01 SEK | 74.31% |
| 2016 FY | - SEK | 36.67% |
| 2016 Q1 | -0.06 SEK | 22.8% |
| 2015 FY | - SEK | -172.73% |
| 2015 Q4 | -0.08 SEK | -5.81% |
| 2015 Q3 | -0.08 SEK | -8.09% |
| 2015 Q2 | -0.07 SEK | 5.16% |
| 2015 Q1 | -0.08 SEK | 37.0% |
| 2014 Q3 | -0.17 SEK | 45.16% |
| 2014 Q1 | -0.37 SEK | -32.14% |
| 2014 Q2 | -0.31 SEK | 16.22% |
| 2014 Q4 | -0.12 SEK | 29.41% |
| 2014 FY | - SEK | 90.09% |
| 2013 Q4 | -0.28 SEK | -21.74% |
| 2013 Q1 | -0.30 SEK | 0.0% |
| 2013 FY | - SEK | 47.89% |
| 2013 Q3 | -0.23 SEK | 23.33% |
| 2013 Q2 | -0.30 SEK | 0.0% |
| 2012 Q4 | -0.30 SEK | 0.0% |
| 2012 FY | - SEK | 40.67% |
| 2011 FY | - SEK | -1695.0% |
| 2010 FY | - SEK | 62.96% |
| 2009 FY | - SEK | 47.57% |
| 2008 FY | - SEK | 5.5% |
| 2007 FY | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| AddLife AB (publ) | 1.56 SEK | 61.538% |
| Biotage AB (publ) | 3.33 SEK | 81.982% |
| Bonesupport Holding AB (publ) | 3.77 SEK | 84.085% |
| Elekta AB (publ) | 3.41 SEK | 82.405% |
| iZafe Group AB (publ) | -0.14 SEK | 528.571% |
| Ortivus AB (publ) | -0.41 SEK | 246.341% |
| Ortivus AB (publ) | -0.41 SEK | 246.341% |
| Q-linea AB (publ) | -3.48 SEK | 117.241% |
| S2Medical AB (publ) | -0.14 SEK | 528.571% |
| Synsam AB (publ) | 2.09 SEK | 71.292% |